Studies have shown that mutated variant of TM6SF2 is associated with development of NAFLD likely through altered hepatic lipid metabolism (102), and higher risk of progression to NASH (103). The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.